Skip to content

Brenda van Dieren joins Gilbert as Laboratory Analyst & Technician

We are very happy to welcome Brenda van Dieren to Gilbert as our new Laboratory Analyst & Technician, joining our team as of August 1st.

Brenda joins us at an exciting time. As Gilbert continues to advance its Smart Precision Inhaler delivery platform and move towards the next stages of drug-device combination product development with our partners, strengthening our laboratory and analytical capabilities is becoming increasingly important.

Brenda brings a strong scientific background to the team. She describes herself as a Biomolecular Scientist, with a Master’s degree and specific experience as a Research Analyst in bispecific monoclonal antibodies and protein chemistry research. In addition, her practical experience working within GLP and GMP environments is highly relevant as Gilbert further develops its laboratory activities and prepares for the next stages of technology and product development.

At Gilbert, Brenda will contribute to our laboratory activities, analytical work, and the characterization and testing of our technology. Her scientific expertise, hands-on experience and practical approach will be a valuable addition to our growing technical team.

Brenda on joining Gilbert:

“I am very excited to join Gilbert and become part of a team working on such an innovative technology. I look forward to learning, contributing to the development of the Smart Precision Inhaler and working together with the team and partners to help turn Gilbert’s platform into solutions that can ultimately make a difference for patients.”

Mehmet Üzümcü, CSTO of Gilbert:

“We are delighted to welcome Brenda to Gilbert. Building a strong team is just as important as developing great technology, and Brenda is a great addition to our growing organization. Her practical laboratory experience, innovative mindset and enthusiasm will be very valuable as we continue to further develop our platform solution in parallel to executing on our first partnership programs.”

Brenda, welcome to Team Gilbert! 🙌

Great to have you with us — and we are looking forward to the journey ahead together.

 

Gilbert is developing the next generation of soft mist inhalers based on a proprietary electrospray (Electro Hydrodynamic Atomization or EHDA) technology to redefine treatment for patients with the next generation of inhaled therapies. Gilbert’s breath actuated smart precision inhaler creates a monodispersed soft mist aerosol, with a customizable droplet size enabling more precise targeting of drugs to desired regions of the lungs, which has the potential to improve the efficacy and safety of treatments. Electrospray enables gentle, efficient delivery of both small and large molecule therapies in both solution and suspension formulations.

Visit us at Gilbert | Redefining treatment for lung patients, follow us on Linkedin or contact us at info@gilbert.eu to learn if electrospray is suitable for your application.

Other posts

Let’s stay in touch!

Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.